logo

AMGN

AmgenยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

AMGN Profile

Amgen Inc.

A company that develops therapeutics based on cellular and molecular biology to treat cardiovascular and inflammatory diseases

Biological Technology
--
06/17/1983
NASDAQ Stock Exchange
28,000
12-31
Common stock
One Amgen Center Drive, Thousand Oaks, California 91320-1799
Develops,manufactures and markets human therapeutic products used in the areas of neurobiology,hematology,infectious disease and inflamations to fightinfection and stimulate the production of blood cells.
Amgen Inc. was founded in California in 1980 and became a Delaware corporation in 1987. The company discovers, develops, manufactures and delivers innovative medicines to fight some of the world's most intractable diseases. The company focuses on areas of high unmet medical needs and uses its expertise to strive for solutions that can significantly improve people's lives while reducing the social and economic burden of disease. The company helped launch the biotech industry more than 40 years ago and has grown into one of the world's leading independent biotech companies.